Empyrean Medical Systems, Inc. has a story that embodies a journey driven by passion, innovation, and a profound mission to revolutionize cancer treatment. At the heart of this journey stands our CEO, Kal Fishman, a visionary whose career in developing medical device technologies for leading companies laid the groundwork for what would become our life’s mission. After co-founding a successful venture in radiotherapy, tragedy struck close to home when Kal’s wife of twenty years and mother of their two children was diagnosed with leukemia. This pivotal moment ignited a fierce desire to revolutionize cancer care. By a stroke of fate, our team stumbled upon a particle physics breakthrough that would become the cornerstone of Empyrean Medical Systems, Inc. Our vision was crystal clear: to bring together a team of unparalleled talent, including radiation oncologists, computational and medical physicists, scientists, engineers, and leading luminary sites, all united by one common goal: to bring Empyrean’s disruptive technologies to clinical use and make a significant impact for patients and clinicians worldwide.

Our Empyrean team of pioneers are pushing advancements in pre-clinical research irradiators, biopharmaceutical therapeutics, informatics, and state-of-the-art external beam technologies, offering new avenues of hope and treatment for patients battling cancer. Empyrean Medical Systems, Inc. is not just about technological innovation; it is a beacon of hope, symbolizing a relentless pursuit of progress in the fight against cancer. As we continue to forge ahead, our journey shines as a testament to the power of human resilience, innovation, and the enduring quest to illuminate the future of cancer care.

We focus on developing innovative products in the following areas:

1. Research and Clinical Devices,

2. Biopharmaceutical Therapies and

3. A leading Informatics platform.

Our team of innovators are determined and ready to improve cancer care for patients and their loved ones… for good!